Cancer Setback Leaves Bristol-Myers Vulnerable to Possible Sale

Cancer Setback Leaves Bristol-Myers Vulnerable to Possible Sale


At a Chicago convention jammed with thousands of doctors in 2015, a buzz of excitement rippled through the hall as a researcher revealed data showing that a Bristol-Myers Squibb Co. drug cocktail had remarkable success in fighting a deadly form of skin cancer.



from Biotech News